Marty J J, Kilpatrick C J, Moulds R F
Br J Clin Pharmacol. 1982 Sep;14(3):399-404. doi: 10.1111/j.1365-2125.1982.tb01998.x.
1 The fluctuations in protein binding of sodium valproate during one dosing interval were studied in five patients stabilized on valproate and taking concurrent anticonvulsant therapy. 2 The patients took their usual morning dose of valproate (400-800 mg) and serial blood samples were collected by venepuncture at 0, 1, 2, 3, 4, and 6 h post-dose. 3 Free valproate was separated from protein bound drug by plasma ultrafiltration and the ultrafiltrate and total plasma valproate concentrations were measured by a gas chromatographic method. 4 The maximum and minimum concentrations in the ultrafiltrates occurred at the same times as in the plasma. However, the percentage fluctuation was always greater in the ultrafiltrates (range 192-412%) compared with the plasma (range 153-374%) due to the concentration-dependent nature of valproate protein binding. 5 If free valproate levels are to be monitored, knowledge of sampling time and dosage history is important for interpretation of the results.
研究了5名服用丙戊酸钠并同时接受抗惊厥治疗的稳定患者在一个给药间隔期内丙戊酸钠蛋白结合的波动情况。
患者服用其常用的早晨剂量丙戊酸钠(400 - 800毫克),并在给药后0、1、2、3、4和6小时通过静脉穿刺采集系列血样。
通过血浆超滤将游离丙戊酸与蛋白结合药物分离,并用气相色谱法测定超滤液和总血浆丙戊酸浓度。
超滤液中的最大和最小浓度与血浆中的出现时间相同。然而,由于丙戊酸蛋白结合的浓度依赖性,超滤液中的波动百分比总是大于血浆中的波动百分比(范围为192 - 412%),而血浆中的波动百分比范围为153 - 374%。
如果要监测游离丙戊酸水平,了解采样时间和用药史对于结果的解释很重要。